|Author (Corporate)||European Commission: DG Health and Food Safety|
|Series Title||Official Journal of the European Union|
|Series Details||L 392, Pages 63-68|
Recommendation adopted by the European Commission on 18 November 2020, setting out guidance for Member States regarding the use of rapid antigen tests to detect SARS-CoV-2 infection. This is in the context of the COVID-19 (coronavirus) pandemic.
This Recommendations builds on previous guidance published by the Commission on COVID-19 testing strategies. It recommends Member States to conduct rapid antigen tests in addition to RT-PCR tests in clearly defined settings where the deployment of antigen tests is appropriate, and with the aim to contain the spread of the coronavirus, to detect SARS-CoV-2 infections and to limit isolation and quarantine measures.
The guidance also contributes to ensuring the free movement of persons and the smooth functioning of the internal market, in times of limited testing capacities. In particular, the Recommendation focuses on criteria to be used for the selection of rapid antigen tests, the settings during which rapid antigen tests are appropriate to be used, test operators, and validation and mutual recognition of rapid antigen tests and their results.
|Subject Tags||Medicines | Medical Devices, Public Health|
|International Organisations||European Union [EU]|